Acquisition Synergy As Xybion has joined Instem, there is a clear cross-sell opportunity to offer customers a unified lifecycle platform from discovery to regulatory submission. Leverage Instem's broader customer base to upsell LIMS, QMS, and AI-enabled analytics, simplifying procurement and integration for life sciences clients.

Platform Upgrade With Pristima Web 10.0 LIMS and Xybion QMS launched recently, there is demand for platform modernization. Propose upgrade paths to integrated, cloud-native solutions with Azure Data Lake Store for analytics and AI-driven quality/compliance workflows to attract mid-market biotech and CROs.

Partner Ecosystem Historical partnerships (EnvolBio, Deciphex) demonstrate a growing ecosystem. Develop co-sell campaigns with these partners to reach end-to-end bioscience workflows, focusing on LIMS-intensive preclinical labs and integrated QC processes.

Regulatory Advantage The product portfolio emphasizes preclinical LIMS, QMS, and regulatory submissions. Target companies needing fast, compliant submissions with integrated data management, offering regulatory-grade data traceability and audit-ready reports to shorten time-to-submission.

Data AI Focus Leverage cloud data architecture (Azure Data Lake) and AI-enabled software to deliver advanced analytics, predictive quality, and study optimization across R&D stages. Sell analytics, dashboards, and data governance as a premium add-on to improve decision making.